This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This could equate to significant savings when considering the large-scale production and distribution of major vaccines. Lower materials usage and easier storage and disposal are further advantages.
It indicates that nanomedicine also has the potential to combat the threat of antibiotic resistance via the use of nanomaterials with intrinsic antibacterial properties, as well as using nanoparticles as effective drugdelivery systems for antibacterial agents.
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. Unfortunately, about 91 percent of this plastic waste from healthcare is not recycled and either ends up in landfills or contaminates natural environments.
As always, we hope your day is productive and meaningful. The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Our choice today is the ever-seasonal pumpkin spice, for those tracking this sort of thing. And please do keep in touch.
In the dynamic landscape of the healthcare sector, the evolution of drugdelivery systems plays a significant role in transforming the management of chronic diseases. These devices reduce injection anxiety, and are useful for patients who prefer a hands-free drugdelivery experience.
They offer several advantages over traditional drugdelivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.
Such deals are inked to not only allow companies to expand their respective product portfolios, but also gain additional capabilities related to emerging technologies. Notably, product development agreements emerged as the most popular type of partnership model adopted by stakeholders in the autoinjectors domain.
This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. There are additional risks to consider with parenteral packaging.
While the industry is seeing advances in alternative drugdelivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry. This heightens the risk of cross contamination, requiring effective containment solutions, especially when handling highly potent powders.
Autoinjectors have revolutionised the convenient delivery of low-volume parenteral drugs. Traditionally, autoinjector combination products have been limited to injection volumes of 0.1 mL, with the world’s first 2.0 mL fill autoinjector having been commercialized just a few years ago. To learn more, download the document below.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content